3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Recruiting
4
Terminated
2
Active not recruiting
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Spinal Cord Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Leukemia
1
Hepatic Veno-Occlusive Disease
1
Glioma
1
Endometrial Hyperplasia
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
77
Docetaxel
69
Capecitabine
64
Trastuzumab
61
Paclitaxel
50
Tamoxifen
47
Epirubicin
47
Letrozole
44
pyrotinib
40
Fulvestrant
37
Doxorubicin
35
Vinorelbine
33
Radiotherapy
32
Carboplatin
32
Anastrozole
28
exemestane
27
Neoadjuvant Therapy
24
Drug Therapy
22
Fluorouracil
21
palbociclib
20
Exercise
20
Chemotherapy, Adjuvant
19
Bevacizumab
18
pertuzumab
16
Goserelin
16
Cisplatin
16
liposomal doxorubicin
15
Mammography
14
Gemcitabine
14
Blood Specimen Collection
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Breast Neoplasms
×
Genetic Testing
×
Clear all
NCT02485626
2016-10-31
HARBOR
The Netherlands Cancer Institute
Unknown
628 enrolled